Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma

Published:2020-11-20 Issue:5 Volume:46 Page:2182-2187
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Syed Mudassir^ORCID,Shah Jehan^ORCID,Montazeri S. Ali,Grajo Joseph R.,Geller Brian,Toskich Beau^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-020-02855-2.pdf

Reference12 articles.

1. Riaz, Ahsun, Rafia Awais, and Riad Salem. "Side effects of yttrium-90 radioembolization." Frontiers in oncology 4 (2014): 198.

2. Seale, Melanie K., et al. "Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree." Radiographics 29.6 (2009): 1725–1748.

3. [3] Costa, A. F., et al. "Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?." Clinical radiology 72.7 (2017): 598-605.

4. Cho, Seung Hyun, et al. "The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study." European journal of radiology 80.2 (2011): e195-e200.

5. Barth, Borna K., et al. "Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion." European journal of radiology 85.4 (2016): 843–849.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis;Colorectal Cancer;2024

2. Evolution of Personalized Dosimetry for Radioembolization of Hepatocellular Carcinoma;Journal of Vascular and Interventional Radiology;2023-07

3. Imaging evaluation following transarterial radioembolization with yttrium-90 microspheres downstaging hepatocellular carcinoma: the first case in China;Quantitative Imaging in Medicine and Surgery;2023-04

4. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group;European Journal of Nuclear Medicine and Molecular Imaging;2022-09-17

5. Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation Study;Journal of Vascular and Interventional Radiology;2021-04